Europe - Euronext Milan - BIT:1ROP - US7766961061 - Common Stock
The current stock price of 1ROP.MI is 379.4 EUR.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SAP.DE | SAP SE | 34.13 | 235.31B | ||
| 1SAP.MI | SAP SE | 34.81 | 240.02B | ||
| DSYA.DE | DASSAULT SYSTEMES SE | 18.55 | 32.60B | ||
| DSY.PA | DASSAULT SYSTEMES SE | 18.02 | 31.67B | ||
| NEM.DE | NEMETSCHEK SE | 47.67 | 10.52B | ||
| 3E1.DE | ELASTIC NV | 32.23 | 6.76B | ||
| AOF.DE | ATOSS SOFTWARE SE | 39.93 | 1.82B | ||
| PLNW.PA | PLANISWARE SA | 33.84 | 1.64B | ||
| 74SW.PA | 74SOFTWARE SA | 24.38 | 1.23B | ||
| TMV.DE | TEAMVIEWER SE | 7.42 | 970.70M | ||
| LSS.PA | LECTRA | 33.18 | 928.73M | ||
| 1INN.DE | INNOSCRIPTA SE | 35.86 | 900.00M |
Roper Technologies, Inc. is a diversified technology company, which engages in the provision of engineered products and solutions for global niche markets. The company is headquartered in Sarasota, Florida and currently employs 18,200 full-time employees. The company operates businesses that design and develop vertical software and technology-enabled products for a variety of defensible niche markets. The firm operates through three segments: Application Software, Network Software and Technology Enabled Products. The Application Software segment includes Aderant, Clinisys, Data Innovations, Deltek, Frontline, IntelliTrans, PowerPlan, Procare, Strata, Transact/CBORD, and Vertafore. The Network Software segment includes ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP, and SoftWriters. The Technology Enabled Products segment includes CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS, and Verathon. Aderant is a comprehensive management software solution for law and other professional services firms. Data Innovations is a software solution that enables the enterprise management of hospitals and independent laboratories.
ROPER TECHNOLOGIES INC
6496 University Parkway
Sarasota FLORIDA US
Employees: 18200
Phone: 19415562601
Roper Technologies, Inc. is a diversified technology company, which engages in the provision of engineered products and solutions for global niche markets. The company is headquartered in Sarasota, Florida and currently employs 18,200 full-time employees. The company operates businesses that design and develop vertical software and technology-enabled products for a variety of defensible niche markets. The firm operates through three segments: Application Software, Network Software and Technology Enabled Products. The Application Software segment includes Aderant, Clinisys, Data Innovations, Deltek, Frontline, IntelliTrans, PowerPlan, Procare, Strata, Transact/CBORD, and Vertafore. The Network Software segment includes ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP, and SoftWriters. The Technology Enabled Products segment includes CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS, and Verathon. Aderant is a comprehensive management software solution for law and other professional services firms. Data Innovations is a software solution that enables the enterprise management of hospitals and independent laboratories.
The current stock price of 1ROP.MI is 379.4 EUR. The price decreased by -23.45% in the last trading session.
ROPER TECHNOLOGIES INC (1ROP.MI) has a dividend yield of 0.82%. The yearly dividend amount is currently 2.56.
1ROP.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
1ROP.MI stock is listed on the Euronext Milan exchange.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1ROP.MI.
The Revenue of ROPER TECHNOLOGIES INC (1ROP.MI) is expected to grow by 13.32% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ChartMill assigns a technical rating of 1 / 10 to 1ROP.MI.
ChartMill assigns a fundamental rating of 5 / 10 to 1ROP.MI. While 1ROP.MI is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months 1ROP.MI reported a non-GAAP Earnings per Share(EPS) of 16.68. The EPS increased by 9.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.34% | ||
| ROA | 4.54% | ||
| ROE | 7.85% | ||
| Debt/Equity | 0.46 |
24 analysts have analysed 1ROP.MI and the average price target is 493.95 EUR. This implies a price increase of 30.19% is expected in the next year compared to the current price of 379.4.
For the next year, analysts expect an EPS growth of 9.91% and a revenue growth 13.32% for 1ROP.MI